"
Team:Freiburg
From 2013.igem.org
(Difference between revisions)
| Line 317: | Line 317: | ||
<div id="text_gross" align="left"><a href="https://2013.igem.org/Team:Freiburg/Highlights"> Highlights </div> </a> | <div id="text_gross" align="left"><a href="https://2013.igem.org/Team:Freiburg/Highlights"> Highlights </div> </a> | ||
All about our <br> Project on one <br> Page! | All about our <br> Project on one <br> Page! | ||
| - | <img src="https://static.igem.org/mediawiki/2013/a/a1/Freiburg_2013_main2_Highlights3.png" height="85" style="position:absolute; top: | + | <img src="https://static.igem.org/mediawiki/2013/a/a1/Freiburg_2013_main2_Highlights3.png" height="85" style="position:absolute; top:685px; left:180px"> |
</div> | </div> | ||
<img id="klammer_klein_rechts" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png"> | <img id="klammer_klein_rechts" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png"> | ||
Revision as of 11:10, 30 September 2013
Our Team developed a universal toolkit, termed uniCAS, that enables customizable gene
regulation in mammalian cells. Therefore, we engineered the recently discovered and highly promising
CRISPR/Cas9 system.
The regulation is based on the RNA-guided Cas9 protein, which allows targeting of specific DNA sequences.
Our toolkit comprises not only a standardized Cas9 protein, but also different effector domains for
efficient gene activation or repression.
|
|
|
|
|
|
|
